Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
![](https://fprimecapital.com/wp-content/uploads/2019/01/alternate-healthcare-illustration-1024x1024.jpg)
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
MIT Technology Review
These fast, cheap tests could help us coexist with covid
April 27, 2022 -
PR Newswire
1upHealth Announces SQL on FHIR® to Easily Ask Hard Questions of Healthcare FHIR® Data and Make Timely Real-World Decisions
April 27, 2022 -
Fierce Biotech
Zolgensma for dementia? AviadoBio gains orphan tag for one-dose gene therapy
April 27, 2022 -
PR Newswire
ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors
April 25, 2022 -
MedCity News
MedCity Pivot Podcast: A conversation with Buoy Health’s chief medical officer
April 21, 2022 -
Business Wire
Artemis Health Launches New Solution to Improve Evaluation and Optimization of Point Solutions
April 21, 2022 -
PR Newswire
Eleos Health and Zero Suicide Institute Join Forces to Incorporate Best Practices for Suicide Prevention Into Eleos’ Platform
April 19, 2022 -
Business Wire
Turnstone Biologics Announces Executive Leadership Appointments
April 19, 2022 -
Globenewswire
Protenus Granted New Patent ‘Methods and Systems for Analyzing Accessing of Drug Dispensing Systems’
April 19, 2022 -
PR Newswire
Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types
April 19, 2022 -
PR Newswire
Innovent Receives NMPA Breakthrough Designation for IBI310, the Anti-CTLA-4 Monoclonal Antibody, Combined with Sintilimab in Advanced Cervical Cancer Treatment
April 13, 2022 -
PR Newswire
Insilico Medicine Announces Advancement of Its Preclinical Candidate for USP1 Synthetic Lethality Target to IND-enabling Studies for Various Oncological Disorders
April 13, 2022 -
GlobeNewswire
Orchard Therapeutics Announces Reimbursement Agreement Making Libmeldy Available for All Eligible MLD Patients in Italy
April 11, 2022 -
PR Newswire
PROOF DIAGNOSTICS SUBMITS REQUEST FOR EMERGENCY USE AUTHORIZATION SEEKING FIRST APPROVAL OF CRISPR-BASED MOLECULAR POINT-OF-CARE COVID-19 TEST
April 7, 2022 -
PR Newswire
Innovent Announces the Approval of Pemazyre® (pemigatinib) by the NMPA for the Treatment of Adults with Locally Advanced or Metastatic Cholangiocarcinoma with A FGFR2 Fusion or Rearrangement As Confirmed By A Validated Diagnostic Test That Have Progressed After at Least One Prior Line of Systemic Therapy
April 6, 2022 -
PR Newswire
Doceree Closes $11 Million Series A Funding Round Led by F-Prime Capital
April 6, 2022 -
PR Newswire
Eleos Health Raises $20M to Unlock In-Session Behavioral Health Voice Data
April 5, 2022 -
Business Wire
Kyruus Welcomes Gail Airasian as General Manager of Emerging Markets as the Company Expands Its Platform to Serve the Broader Digital Health Market
April 5, 2022 -
PR Newswire
TraceLink Announces Product Availability Intelligence, Enabling Manufacturers to Predict Drug Shortages up to 90 Days in Advance with Greater Than 80% Accuracy
April 5, 2022 -
PR Newswire
HealthTap Joins Buoy Health’s Navigation Initiative to Match More People with the Right Health Care
April 5, 2022 -
Business Wire
Rallybio Appoints Christine A. Nash and Hui Liu, Ph.D., to Its Board of Directors
April 4, 2022 -
Business Wire
Ivenix to be Acquired by Fresenius Kabi
March 31, 2022 -
PR Newswire
Insilico Medicine Announces Strategic Collaboration with EQRx to Jointly Advance AI-driven Drug Discovery, Development and Commercialization for Multiple Targets
March 29, 2022 -
PR Newswire
AmplifyMD Raises $23 Million to Improve Patient Access to Specialty Care
March 28, 2022 -
PR Newswire
Innovent and Lilly Expand Strategic Partnership in Oncology
March 27, 2022 -
Business Wire
WellAir Launches a New Advanced Air Cleaning Device in Europe with Independently Tested Industry Leading 99.9% Effectiveness Against Airborne Pathogens
March 22, 2022 -
PR Newswire
AppliedVR Renames Its FDA-approved Virtual Reality Therapeutic ‘RelieVRx’ and Announces Three-month Durability Study Results
March 22, 2022 -
PR Newswire
Aerium Therapeutics launches to develop novel therapeutics against COVID-19 and future pandemic threats
March 22, 2022 -
Fierce Healthcare
Carrot Fertility rolls out age-inclusive benefits for menopause, low testosterone
March 16, 2022 -
PR Newswire
WellHive Announces Partnership with Kyruus to Integrate Systems and Optimize Care Navigation for Veterans
March 10, 2022 -
Globenewswire
Equip and Magellan Healthcare Collaborate to Offer Virtual Eating Disorder Treatment in California
March 10, 2022 -
Business Wire
Atalanta Therapeutics Appoints Alfred Sandrock to Board of Directors
March 10, 2022 -
Business Wire
UPMC and Kyruus Launch Strategic Partnership to Transform Digital Patient Access and Care Navigation
March 9, 2022 -
PR Newswire
Proximie Selected As A Featured Innovator at LSI 2022 Medtech Investor Summit
March 3, 2022 -
Globenewswire
Owkin welcomes leading immuno-oncology professor as Chief Medical Officer and senior pharma exec as SVP Data Science
March 2, 2022 -
PR Newswire
Rialtic Completes Series A Extension Bringing Total Round to $45 Million
March 2, 2022 -
PR Newswire
Insilico Announces Successful Completion of Phase 0 Microdose Trial and Initiates Phase I Clinical Trial for its First AI-discovered Anti-fibrotic Product Candidate with Novel Target
February 24, 2022 -
Forbes
Benchling Expands Its Science Software Capabilities With Its First Acquisition
February 24, 2022 -
PR Newswire
Avidity Biosciences Appoints Steve Hughes, M.D., as Chief Medical Officer
February 23, 2022 -
PR Newswire
Independence Blue Cross and Patina announce agreement to offer Medicare Advantage members a new primary care experience
February 22, 2022 -
PR Newswire
Innovent Announces First Patient Dosing of Universal “Modular” CAR-T Cell product IBI345
February 20, 2022 -
Business Wire
NOCD Selects Violet to Enhance Cultural and Identity Awareness Training to Therapists To Deliver More Personalized Care
February 16, 2022 -
GlobeNewswire
Equip Raises $58 Million Series B Funding Round to Revolutionize Eating Disorder Treatment
February 16, 2022 -
Fierce Healthcare
Expressable grabs $15M to expand access to online speech therapy
February 9, 2022 -
PR Newswire
Centivo survey reveals devastating toll of the healthcare affordability crisis on US workers
February 8, 2022 -
PR Newswire
EmpiRx Health Reaffirms Commitment to Employees, Partners with Valor Performance to Strengthen Leadership & Employee Experience
February 4, 2022 -
Business Wire
Kyruus Announces Record-Breaking Customer Growth in 2021, Welcoming HealthSparq and Connecting Millions of People with Care
February 3, 2022 -
PR Newswire
AGSAA, Biogen, LunaPBC, and Genetic Alliance Launch Community-Led Discovery Program for Aicardi-Goutières Syndrome
February 3, 2022 -
GlobeNewswire
Orchard Therapeutics Announces Historic Agreement Making Libmeldy Available by NHS England for MLD Patients
February 3, 2022 -
Business Wire
Four Seasons Astir Palace Hotel Partners with WellAir to Improve Indoor Air Quality
February 1, 2022 -
PR Newswire
Insilico Medicine Applauded by Frost & Sullivan for Enabling Rapid and Cost-Effective Drug Discovery and Development with Its Pharma.AI Platform
January 25, 2022 -
PR Newswire
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Hong Kong Market for the Treatment of Adults With Locally Advanced Or Metastatic Cholangiocarcinoma With A FGFR2 Fusion Or Rearrangement That Have Progressed After At Least One Prior Line Of Systemic Therapy
January 24, 2022 -
Endpoints News
F-Prime backed startup nabs another $50M in bid to scale up AI R&D software
January 24, 2022 -
BioSpace
Xilio Therapeutics Announces Initiation of Patient Dosing in Phase 1/2 Clinical Trial of XTX202 for the Treatment of Patients with Solid Tumors
January 20, 2022 -
GlobeNewswire
CENTOGENE Joins Forces With Insilico Medicine for Niemann-Pick Disease Type C (NPC) Target Discovery, Applying Artificial Intelligence (AI) to Accelerate Orphan Drug Development
January 20, 2022 -
Business Wire
WellAir Announces Strategic Partnership with the Association for Professionals in Infection Control and Epidemiology (APIC)
January 20, 2022 -
Business Wire
ShouTi Strengthens Board With Appointment of Daniel G. Welch as Chairman
January 20, 2022 -
PR Newswire
Icon Health Joins Buoy Health’s Navigation Initiative to Match More People with the Right Health Care
January 19, 2022 -
Business Wire
Ami Bavishi Joins Rallybio to Lead Investor Relations and Corporate Communications
January 18, 2022 -
Business Wire
Fort HealthCare Partners with Ivenix to Provide Unprecedented Infusion Safety
January 13, 2022 -
PR Newswire
Health Care Leader Jay Meyers Joins Quartet Health as Chief Growth Officer to Accelerate National Growth to Deliver Speed to Quality Mental Health Care for All
January 13, 2022 -
GlobeNewswire
Adagene Announces First Patients with Advanced Non-Small Cell Lung Cancer Dosed in Phase 1b/2 Clinical Trial of ADG106 in Combination with Nivolumab in Singapore
January 13, 2022 -
GlobeNewswire
Wellframe Achieves Momentous Growth in 2021, Accelerating Its Ability to Modernize the Member Experience
January 12, 2022 -
Business Wire
SonderMind Announces Appointment of Brannan Schell to New Chief Operating Officer Position
January 12, 2022 -
PR Newswire
Global Health Technology Platform – Proximie – Announces Partnership With Vodafone Business to Increase Access to Surgical Healthcare and Training
January 11, 2022 -
PR Newswire
Fosun Pharma and Insilico Medicine Announce a Strategic, AI-driven Drug Discovery and Development Collaboration to Jointly Advance Multiple Targets
January 11, 2022 -
GlobeNewswire
Sana Biotechnology Obtains Exclusive License from National Institutes of Health for CD22 CAR Construct
January 11, 2022 -
FierceBiotech
Pfizer re-ups gene editing interest with $300M Beam pact, $1.35B in biobucks
January 10, 2022 -
GlobeNewswire
Singular Genomics Partners with Lexogen to Enable RNA Library Prep for the G4 Sequencing Platform
January 10, 2022 -
PR Newswire
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct
January 10, 2022 -
PR Newswire
Laekna Therapeutics and Innovent Biologics obtain IND approval for combination therapy in patients with specific types of solid tumors who have been refractory to treatment with PD-1/PD-L1 inhibitors
January 9, 2022 -
PR Newswire
RareCyte® Inc. reports significant 2021 growth of Precision Biology™ Services business and customer uptake of Orion™ Spatial Biology instruments and reagents
January 6, 2022 -
Business Wire
Nomi Health Acquires Artemis Health to Accelerate Transformation of U.S. Healthcare with Actionable Insights
January 6, 2022 -
PR Newswire
Insilico Medicine Announces the Nomination of Two Preclinical Candidates for PHD2, 12 Months After Program Initiation
January 5, 2022 -
Renaissance Capital Report
Gene therapy biotech Affinia Therapeutics files for a $100 million IPO
January 4, 2022 -
PR Newswire
TraceLink Wins Comparably 2021 Best Company Culture Award
January 4, 2022 -
GlobeNewswire
Apellis and Sobi Announce EU Approval of Aspaveli® (pegcetacoplan) for Treatment of PNH
December 17, 2021 -
FierceBiotech
Amgen, Owkin study shows cardiac-predicting AI outperforms traditional clinical methods
December 17, 2021 -
GlobeNewswire
Singular Genomics Launches the G4 Sequencing Platform
December 16, 2021 -
PR Newswire
BioMarin and Skyline Therapeutics Announce Strategic Collaboration to Develop Novel Gene Therapies for Cardiovascular Diseases
December 16, 2021 -
GlobeNewswire
Affinia Therapeutics Appoints Thomas Leggett as Chief Financial Officer
December 14, 2021 -
Business Wire
Virtua Health Selects Kyruus’ Digital Platform to Simplify How Consumers Access Care Online
December 14, 2021 -
PR Newswire
Quartet Health Acquires InnovaTel Telepsychiatry, Making Shared Vision of Speed to Quality Mental Health Care for All a Reality
December 13, 2021 -
GlobeNewswire
Acacia Pharma Announces Successful Completion of BARHEMSYS® Post-approval Requirement Study in Patients with Severe Renal Impairment
December 13, 2021 -
GlobeNewswire
Adagene Presents Preclinical Data Showcasing Best-in-Class Profiles for ADG153, an Anti-CD47 SAFEbody® and ADG152, a CD20xCD3 Bispecific T-cell Engager POWERbody™
December 13, 2021 -
FierceHealthcare
Quartet picks up InnovaTel Telepsychiatry to expand its reach in the digital mental health market
December 13, 2021 -
GlobeNewswire
Beam Therapeutics Outlines Long-term Strategy for Base Editing Programs in Sickle Cell Disease and Provides Preclinical Data Updates at ASH
December 12, 2021 -
GlobeNewswire
Carrot Fertility Expands Executive Team, Hires Former Aetna Executive as Chief Commercial Officer
December 9, 2021 -
PR Newswire
1upHealth Named as “Most Innovative Digital Health Startup” by CB Insights’ Digital Health 150
December 9, 2021 -
MobiHealthNews
Quartet Health snaps up fellow mental health company InnovaTel Telepsychiatry
December 9, 2021
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.